Comparative analysis of genomic landscape reveals heterogeneity in HER2-positive primary breast cancers and residual disease following neoadjuvant therapy
- Resource Type
- Journal
- Source
CANCER RESEARCH ; FEB 2020, 80 4, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445